EXAPRIDE

Main information

  • Trade name:
  • EXAPRIDE 1 INJ
  • Dosage:
  • 250MCG/ML
  • Pharmaceutical form:
  • INJ
  • Composition:
  • 1
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EXAPRIDE 1 INJ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

29-8-2018

BYDUREON (AstraZeneca AB)

BYDUREON (AstraZeneca AB)

BYDUREON (Active substance: exenatide) - Centralised - Variation - Commission Decision (2018)5776 of Wed, 29 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2020/X/48/G

Europe -DG Health and Food Safety

13-7-2018

Byetta (AstraZeneca AB)

Byetta (AstraZeneca AB)

Byetta (Active substance: exenatide) - Centralised - Yearly update - Commission Decision (2018)4711 of Fri, 13 Jul 2018

Europe -DG Health and Food Safety